RARE MALIGNANT SKIN TUMOURS OF THE HEAD AND NECK

Aleksandar Oroz, Zorana Bokun, Biljana Lazovic, Ognjen Cukic, Svetlana Valjarevic

Abstract


Introduction: Malignant skin tumors in the majority of cases arise from the squamous  epithelium, although they may occur in other accompanying skin structures, such as skin adnexa (hair follicle, sweat and sebaceous glands), as well as soft tissues participating in the building of skin structure, such as muscles, fibrous, fatty tissue and cartilagе. Those tumors may also have a neuroendocrine origin or may arise from a premalignant lesion (solar keratosis and lentigo maligna). Regardless of their origin, they usually present as a nodule or longstanding, non-healing ulceration. Their early recognition enhances the treatment results and decreases the possibility of complications (invasion of deeper tissue structures and occurrence of regional and distant metastases).

Material and methods: Our retrospective study included 100 patients of both sexes surgically treated for skin malignancy in the Department for Otorhinolaryngology and Maxillofacial surgery of the Clinical Hospital Centre “Zemun” , Belgrade, Serbia.

The goal of this paper is to highlight the frequency of rare malignant tumors compared to the more frequent ones and consider the most appropriate clinical-diagnostic approach as well as the treatment modality for the patient.

Conclusion: Our study has shown that the most frequent tumor of the head and neck skin is basal cell carcinoma.


Keywords


rare malignant skin tumor, skin tumor frequency, metastases, surgery, therapy.

Full Text:

PDF

References


Zhang S, Ma Y, Ma T, Wang Z. Low-grade myofibroblastic sarcoma of the orbit: A case report and literature review. Medicine (Baltimore). 2017; 96 (51): e9172.

Rat C, Hild S, Rault Sérandour J, Gaultier A, Quereux G, Dreno B, et al. Use of smartphones for early detection of melanoma: systematic review. J Med Internet Res. 2018; 20(4):e135.

Capone E, Giansanti F, Ponziani S, Lamolinara A, Iezzi M, Cimini A, et al. EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma. Oncotarget. 2017; 8(56):95412-24.

Haskins CP, Nurkic S, Fredenburg KM, Dziegielewski PT, Mendenhall WM. Primary orbital melanoma treated with orbital exenteration and postoperative radiotherapy: A case report and review of the literature. Head Neck. 2018;40(3):E17-20.

Amin SM, Cooper C, Yélamos O, Lee CY, Sholl LM, de la Fouchardiere A, et al. Combined cutaneous tumors with a melanoma component: a clinical, histologic, and molecular study. J Am Acad Dermatol. 2015; 73(3):451-6.

Matutes E. The 2017 WHO update on mature T- and natural killer (NK) cell neoplasms. Int J LabHematol. 2018; 40(suppl 1):97-103.

Furdová A, Horkovičová K, Babál P, Kobzová D, Ondrušová M. Non-melanotic Tumors of the Eyelids Skin and Inner Corner - Basocellular Carcinoma. Cesk Slov Oftalmol. 2015; 71(6):293-301.

Ugwu DI, Okoro UC, Ukoha PO, Gupta A, Okafor SN. Novel anti-inflammatory and analgesic agents: synthesis, molecular docking and in vivo studies. J Enzyme Inhib Med Chem. 2018; 33(1):405-15.

Raj A, Ramesh G, Pathak S. Assessment of hospital based prevalence of oral cancer among population of Kanpur, Uttar Pradesh. J ExpTher Oncol. 2018; 12(3):193-9.

Cohen PR. Basal cell carcinoma with myoepithelial differentiation: case report and literature review. Cureus. 2018; 10(1):e2081.

Dhir G, Makkar M, Suri V, Dubey V. Familial dermal eccrine cylindromatosis with emphasis on histology and genetic mapping. Ann Med Health Sci Res. 2013;3(suppl 1):S3-6.

Russell L, Ugalde A, Milne D, Krishnasamy M, O SeungChul E, Austin DW et al. Feasibility of an online mindfulness-based program for patients with melanoma: study protocol for a randomised controlled trial. Trials. 2018; 19(1):223.

Ahlgrimm-Siess V, Laimer M, Rabinovitz HS, Oliviero M, Hofmann-Wellenhof R, Marghoob AA, et al. Confocal microscopy in skin cancer. Curr Dermatol Rep. 2018; 7(2):105-18.

Giantini Larsen A, Grannan BL, Lee CK, Koch MJ, Williams EA, Frosch MP, et al. Malignant melanoma metastatic to oligodendroglioma: case report and literature review of tumor-to-tumor metastasis to gliomas. J Neuropathol Exp Neurol. 2018;77(7): 549-54.

Taylor L, Hood K, Reisch L, Elmore J, Piepkorn M, Barnhill R, et al. Influence of variability in assessment of Breslow thickness, mitotic rate and ulceration among U.S. pathologists interpreting invasive melanoma, for the purpose of AJCC staging. J Cutan Pathol. 2018;45(8):588-96.

de Castro MS, Reis BSA, Nogueira DA, de Carli ML, Hanemann JAC, Pereira AAC, et al. Primary oral melanoma: a clinicopathologic review and case presentation. Quintessence Int. 2017; 48(10):815-27.

Novotná K, Arenbergerová M, Miletín J, Kníže J, Šandera V, Schwarzmannová K, et al. Surgical treatment of melanoma. Acta Chir Plast. 2018 Spring; 59(3-4):149-55.

Gloster HM, Brodland DG. The epidemiology of skin cancer. Dermatol Surg.1996;22(3): 217–26.




DOI: http://dx.doi.org/10.24125/sanamed.v13i3.245

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 aleksandar oroz, zorana bokun, biljana lazovic, ognjen čukić, svetlana valjarevic

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.